Literature DB >> 18586755

Antibody technology in proteomics.

Dirk Saerens1, Gholamreza Hassanzadeh Ghassabeh, Serge Muyldermans.   

Abstract

Today's proteomic analyses are generating increasing numbers of biomarkers, making it essential to possess highly specific probes able to recognize those targets. Antibodies are considered to be the first choice as molecular recognition units due to their target specificity and affinity, which make them excellent probes in proteomics. In the post-genomic era and with high-throughput techniques available, the goal is to discriminate between all individual proteins from the proteome including their splice variants and post-translationally modified derivatives. Aided by advances in generation, selection and engineering of antibody-based recognition units, antibody fragments provide tools for detection of high- as well as low-abundant analytes even in complex, non-fractionated proteomes in conjunction with usage of small amounts of samples and reagents. In addition, large consortia aim at generating vast numbers of antibody-based recognition units suitable for future diagnostics and therapeutics.

Mesh:

Substances:

Year:  2008        PMID: 18586755     DOI: 10.1093/bfgp/eln028

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  3 in total

Review 1.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  High-level expression of Camelid nanobodies in Nicotiana benthamiana.

Authors:  Yi-Hui Audrey Teh; Tony A Kavanagh
Journal:  Transgenic Res       Date:  2009-10-28       Impact factor: 2.788

3.  Isolation and optimization of camelid single-domain antibodies: Dirk Saerens' work on nanobodies.

Authors:  Dirk Saerens
Journal:  World J Biol Chem       Date:  2010-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.